Exact Mass: 307.256

Exact Mass Matches: 307.256

Found 48 metabolites which its exact mass value is equals to given mass value 307.256, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Pumiliotoxin A

Pumiliotoxin A

C19H33NO2 (307.2511)


   

Fingolimod

2-amino-2-(2-(4-Octylphenyl)ethyl)-1,3-propanediol hydrochloride

C19H33NO2 (307.2511)


L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants > L04AA - Selective immunosuppressants D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents > D000081243 - Sphingosine 1 Phosphate Receptor Modulators COVID info from Guide to PHARMACOLOGY, DrugBank, clinicaltrial, clinicaltrials, clinical trial, clinical trials C308 - Immunotherapeutic Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Pumiliotoxin A

6-(6-hydroxy-2,5-dimethyloct-4-en-1-ylidene)-8-methyl-hexahydroindolizin-8-ol

C19H33NO2 (307.2511)


   

(R)-(-)-Dysidazirine

(R)-(-)-Dysidazirine

C19H33NO2 (307.2511)


   

Fingolimod

Fingolimod

C19H33NO2 (307.2511)


L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants > L04AA - Selective immunosuppressants D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents > D000081243 - Sphingosine 1 Phosphate Receptor Modulators COVID info from Guide to PHARMACOLOGY, DrugBank, clinicaltrial, clinicaltrials, clinical trial, clinical trials C308 - Immunotherapeutic Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

2-hydroxy-2-methyl-N-{trans-1-methyl-4-[(2E,4E)-6-methylhepta-2,4-dien-2-yl]cyclohexyl}-propanamide

2-hydroxy-2-methyl-N-{trans-1-methyl-4-[(2E,4E)-6-methylhepta-2,4-dien-2-yl]cyclohexyl}-propanamide

C19H33NO2 (307.2511)


   

octahydro-6-(4-hydroxy-2,5-dimethyl-5-octenylidene)-8-methyl-8-indolizinol

octahydro-6-(4-hydroxy-2,5-dimethyl-5-octenylidene)-8-methyl-8-indolizinol

C19H33NO2 (307.2511)


   

cylindricine C

cylindricine C

C19H33NO2 (307.2511)


   

3-O-Tetradecanoyl-1-cyano-2-methyl-1-propene

3-O-Tetradecanoyl-1-cyano-2-methyl-1-propene

C19H33NO2 (307.2511)


   

(8S,Z)-6-((2R,E)-4-hydroxy-2,5-dimethyloct-5-en-1-ylidene)-8-methyloctahydroindolizin-8-ol

(8S,Z)-6-((2R,E)-4-hydroxy-2,5-dimethyloct-5-en-1-ylidene)-8-methyloctahydroindolizin-8-ol

C19H33NO2 (307.2511)


   

(2R)-1-((8S,Z)-8-hydroxy-8-methylhexahydroindolizin-6(5H)-ylidene)-2,5-dimethyloctan-4-one

(2R)-1-((8S,Z)-8-hydroxy-8-methylhexahydroindolizin-6(5H)-ylidene)-2,5-dimethyloctan-4-one

C19H33NO2 (307.2511)


   

(7R)-8-((8S,Z)-8-hydroxy-8-methylhexahydroindolizin-6(5H)-ylidene)-4,7-dimethyloctan-3-one

(7R)-8-((8S,Z)-8-hydroxy-8-methylhexahydroindolizin-6(5H)-ylidene)-4,7-dimethyloctan-3-one

C19H33NO2 (307.2511)


   

(8S,Z)-6-((2R,E)-6-hydroxy-2,5-dimethyloct-4-en-1-ylidene)-8-methyloctahydroindolizin-8-ol

(8S,Z)-6-((2R,E)-6-hydroxy-2,5-dimethyloct-4-en-1-ylidene)-8-methyloctahydroindolizin-8-ol

C19H33NO2 (307.2511)


   

(8S,Z)-6-((2R,E)-7-hydroxy-2,5-dimethyloct-4-en-1-ylidene)-8-methyloctahydroindolizin-8-ol

(8S,Z)-6-((2R,E)-7-hydroxy-2,5-dimethyloct-4-en-1-ylidene)-8-methyloctahydroindolizin-8-ol

C19H33NO2 (307.2511)


   

(7R,8R,E)-6-((R,E)-2,5-dimethyloct-4-en-1-ylidene)-8-methyloctahydroindolizine-7,8-diol

(7R,8R,E)-6-((R,E)-2,5-dimethyloct-4-en-1-ylidene)-8-methyloctahydroindolizine-7,8-diol

C19H33NO2 (307.2511)


   

FTY720

2-amino-2-[2-(4-octylphenyl)ethyl]-1,3-propanediol, hydrochloride

C19H33NO2 (307.2511)


   

R-Dysidazirine

methyl 3-(pentadec-1E-enyl)-2H-azirine-2S-carboxylate

C19H33NO2 (307.2511)


   

Eicosapentaenoic Acid-d5

Eicosapentaenoic Acid-d5

C20H25D5O2 (307.256)


   

EPA (d5)

5Z,8Z,11Z,14Z,17Z-eicosapentaenoic acid (d5)

C20H25D5O2 (307.256)


   

N-(2,6-dicyclohexyloxan-4-yl)acetamide

N-(2,6-dicyclohexyloxan-4-yl)acetamide

C19H33NO2 (307.2511)


   

sodium N-tetradecyl-beta-alaninate

sodium N-tetradecyl-beta-alaninate

C17H34NNaO2 (307.2487)


   

1,7,7-trimethyl-N,N-bis(2-methylpropyl)-2-oxo-4-bicyclo[2.2.1]heptanecarboxamide

1,7,7-trimethyl-N,N-bis(2-methylpropyl)-2-oxo-4-bicyclo[2.2.1]heptanecarboxamide

C19H33NO2 (307.2511)


   

(11Z,14Z)-Icosadienoate

(11Z,14Z)-Icosadienoate

C20H35O2- (307.2637)


A polyunsaturated fatty acid anion that is the conjugate base of (11Z,14Z)-icosadienoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(8Z,11Z)-Eicosa-8,11-dienoate

(8Z,11Z)-Eicosa-8,11-dienoate

C20H35O2- (307.2637)


   

An 11,13-eicosadienoate

An 11,13-eicosadienoate

C20H35O2- (307.2637)


   

(11E,13Z)-eicosadienoate

(11E,13Z)-eicosadienoate

C20H35O2- (307.2637)


   

(11Z,13E)-eicosadienoate

(11Z,13E)-eicosadienoate

C20H35O2- (307.2637)


   

(11E,13E)-eicosa-11,13-dienoate

(11E,13E)-eicosa-11,13-dienoate

C20H35O2- (307.2637)


   

(11Z, 13Z)-icosa-11,13-dienoate

(11Z, 13Z)-icosa-11,13-dienoate

C20H35O2- (307.2637)


   

Octahydro-6-(6-hydroxy-2,5-dimethyl-4-octen-1-ylidene)-8-methylindolizin-8-ol

Octahydro-6-(6-hydroxy-2,5-dimethyl-4-octen-1-ylidene)-8-methylindolizin-8-ol

C19H33NO2 (307.2511)


   

(6Z,8S)-6-[(E,6S)-6-hydroxy-2,5-dimethyloct-4-enylidene]-8-methyl-1,2,3,5,7,8a-hexahydroindolizin-8-ol

(6Z,8S)-6-[(E,6S)-6-hydroxy-2,5-dimethyloct-4-enylidene]-8-methyl-1,2,3,5,7,8a-hexahydroindolizin-8-ol

C19H33NO2 (307.2511)


   

(5Z,8Z)-eicosadienoate

(5Z,8Z)-eicosadienoate

C20H35O2- (307.2637)


   

(2E,4E)-icosa-2,4-dienoate

(2E,4E)-icosa-2,4-dienoate

C20H35O2- (307.2637)


   

icosadienoate

icosadienoate

C20H35O2 (307.2637)


A polyunsaturated fatty acid anion that is the conjugate base of icosadienoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(8Z,11Z)-icosadienoate(1-)

(8Z,11Z)-icosadienoate(1-)

C20H35O2 (307.2637)


An icosadienoate obtained by deprotonation of the carboxy group of (8Z,11Z)-icosadienoic acid; major species at pH 7.3.

   

NA-Histamine 13:0

NA-Histamine 13:0

C18H33N3O (307.2623)


   

methyl (2r)-3-[(1e)-pentadec-1-en-1-yl]-2h-azirine-2-carboxylate

methyl (2r)-3-[(1e)-pentadec-1-en-1-yl]-2h-azirine-2-carboxylate

C19H33NO2 (307.2511)


   

methyl 3-(pentadec-1-en-1-yl)-2h-azirine-2-carboxylate

methyl 3-(pentadec-1-en-1-yl)-2h-azirine-2-carboxylate

C19H33NO2 (307.2511)


   

3-o-tetradecanoyl-1-cyano-2-methyl-1-propene

NA

C19H33NO2 (307.2511)


{"Ingredient_id": "HBIN009382","Ingredient_name": "3-o-tetradecanoyl-1-cyano-2-methyl-1-propene","Alias": "NA","Ingredient_formula": "C19H33NO2","Ingredient_Smile": "CCCCCCCCCCCCCC(=O)OCC(=CC#N)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21026","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(6z,8s)-6-[(4e,6s)-6-hydroxy-2,5-dimethyloct-4-en-1-ylidene]-8-methyl-hexahydroindolizin-8-ol

(6z,8s)-6-[(4e,6s)-6-hydroxy-2,5-dimethyloct-4-en-1-ylidene]-8-methyl-hexahydroindolizin-8-ol

C19H33NO2 (307.2511)


   

5-hexyl-3-(hydroxymethyl)-decahydropyrrolo[2,1-j]quinolin-7-one

5-hexyl-3-(hydroxymethyl)-decahydropyrrolo[2,1-j]quinolin-7-one

C19H33NO2 (307.2511)


   

methyl 3-[(1z)-pentadec-1-en-1-yl]-2h-azirine-2-carboxylate

methyl 3-[(1z)-pentadec-1-en-1-yl]-2h-azirine-2-carboxylate

C19H33NO2 (307.2511)


   

(6z,8s,8as)-6-[(2r,4z,6r)-6-hydroxy-2,5-dimethyloct-4-en-1-ylidene]-8-methyl-hexahydroindolizin-8-ol

(6z,8s,8as)-6-[(2r,4z,6r)-6-hydroxy-2,5-dimethyloct-4-en-1-ylidene]-8-methyl-hexahydroindolizin-8-ol

C19H33NO2 (307.2511)


   

2-hydroxy-2-methyl-n-[(1r,4r)-1-methyl-4-[(2e,4e)-6-methylhepta-2,4-dien-2-yl]cyclohexyl]propanimidic acid

2-hydroxy-2-methyl-n-[(1r,4r)-1-methyl-4-[(2e,4e)-6-methylhepta-2,4-dien-2-yl]cyclohexyl]propanimidic acid

C19H33NO2 (307.2511)


   

(3r,5s,7ar,11ar)-5-hexyl-3-(hydroxymethyl)-decahydropyrrolo[2,1-j]quinolin-7-one

(3r,5s,7ar,11ar)-5-hexyl-3-(hydroxymethyl)-decahydropyrrolo[2,1-j]quinolin-7-one

C19H33NO2 (307.2511)


   

(6z,8s,8as)-6-[(2r,4e,6s)-6-hydroxy-2,5-dimethyloct-4-en-1-ylidene]-8-methyl-hexahydroindolizin-8-ol

(6z,8s,8as)-6-[(2r,4e,6s)-6-hydroxy-2,5-dimethyloct-4-en-1-ylidene]-8-methyl-hexahydroindolizin-8-ol

C19H33NO2 (307.2511)


   

2-hydroxy-2-methyl-n-[1-methyl-4-(6-methylhepta-2,4-dien-2-yl)cyclohexyl]propanimidic acid

2-hydroxy-2-methyl-n-[1-methyl-4-(6-methylhepta-2,4-dien-2-yl)cyclohexyl]propanimidic acid

C19H33NO2 (307.2511)